NCT06318637

Brief Summary

The purpose of this study is to assess, via caregiver questionnaire, the acceptability and feasibility of implementing a bedtime routine for newborns.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

April 18, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 12, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 12, 2025

Completed
Last Updated

September 24, 2025

Status Verified

June 1, 2025

Enrollment Period

1.3 years

First QC Date

March 13, 2024

Last Update Submit

September 23, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Bedtime Routine Acceptability and Feasibility to Caregivers

    Will collect agreement data to statements on bedtime routine acceptability using a 5-point Likert scale, ranging from strongly agree to strongly disagree. Will collect bedtime routine information, including wash up/bath, massage/apply lotion and quiet activity.

    At Day 10

  • Bedtime Routine Acceptability and Feasibility to Caregivers

    Will collect agreement data to statements on bedtime routine acceptability using a 5-point Likert scale, ranging from strongly agree to strongly disagree. Will collect bedtime routine information, including wash up/bath, massage/apply lotion and quiet activity.

    At Day 17

  • Bedtime Routine Acceptability and Feasibility to Caregivers

    Will collect agreement data to statements on bedtime routine acceptability using a 5-point Likert scale, ranging from strongly agree to strongly disagree. Will collect bedtime routine information, including wash up/bath, massage/apply lotion and quiet activity.

    At 3 months

  • Bedtime Routine Acceptability and Feasibility to Caregivers

    Will collect agreement data to statements on bedtime routine acceptability using a 5-point Likert scale, ranging from strongly agree to strongly disagree. Will collect bedtime routine information, including wash up/bath, massage/apply lotion and quiet activity.

    At 6 months

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Participants in the control group will follow their typical daily activities with their baby throughout the study, including their typical bathing, skincare, and sleep practices.

Other: Daily Activities

Interventional Group (Wash/Shampoo and Lotion)

EXPERIMENTAL

Participants in the intervention group will use the provided wash/shampoo, and face and body lotion for their baby. At Baseline, participants caregivers in the intervention group will be provided with instructions for institution of a daily bedtime routine for their infant, which includes a massage with a moisturizing lotion.

Other: Baby Wash/ShampooOther: Body Lotion

Interventions

Marketed baby wash/shampoo to be used as needed.

Interventional Group (Wash/Shampoo and Lotion)

Participants to follow their typical daily activities with their baby.

Control Group

Marketed body lotion to be used as needed.

Interventional Group (Wash/Shampoo and Lotion)

Eligibility Criteria

Age2 Weeks+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Infant:
  • Full term at birth (gestational age greater than or equal to \[\>=\] 37 weeks)
  • A singleton birth. (Having other infants/children in the household will be allowed but only 1 child per household may be enrolled)
  • Breastfed, formula-fed, or combination
  • Caregiver:
  • Able to read, write, speak, and understand English
  • Must be the parent (biological or adoptive) and legal guardian of the infant participant who is willing and able to present proof of legal guardianship (example: birth certificate/hospital discharge paperwork along with valid ID of legal guardian, etc.)

You may not qualify if:

  • Caregiver and infant:
  • Has known allergies or adverse reactions to common topical skincare products or the ingredients in the investigational study materials
  • Has a history of or a concurrent health condition/situation which, in the opinion of the Principal Investigator (PI) or Study Physician, may put the individual at significant risk, confound the study results, or interfere significantly with the individual's participation in the study
  • Is simultaneously participating in any other clinical study or has participated in a clinical study since infant's birth
  • Is an employee/contractor or immediate family member of the PI, Study Site, or Sponsor
  • Presents with a skin condition that may influence the outcome of the study (specifically psoriasis, eczema, atopic dermatitis, or erythema)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SGS North America, Inc.

Richardson, Texas, 75081, United States

Location

MeSH Terms

Interventions

Activities of Daily Living

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Nancy Rodgers, Ph.D.

    SGS North America, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2024

First Posted

March 19, 2024

Study Start

April 18, 2024

Primary Completion

August 12, 2025

Study Completion

August 12, 2025

Last Updated

September 24, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Johnson \& Johnson Consumer Inc. has an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.

More information

Locations